You are here

  • Home
  • Archive
  • Volume 4, Issue Suppl 1
  • 428 Pre-emptive treatment for asymptomatic serological reactivation in lupus nephritis patients – impact on clinical flare rate and renal function

Article info

Article menu

Download PDFPDF

Poster Session
SLE Epidemiology and risk factors
428 Pre-emptive treatment for asymptomatic serological reactivation in lupus nephritis patients – impact on clinical flare rate and renal function
Free

Authors

Citation

Yap D, Ma M, Mok M, et al
428 Pre-emptive treatment for asymptomatic serological reactivation in lupus nephritis patients – impact on clinical flare rate and renal function
Lupus Science & Medicine 2017;4:doi: 10.1136/lupus-2017-000215.428

Publication history

  • First published March 24, 2017.
Online issue publication 
February 18, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions